Conclusions on the management of heart failure | Zendy

Karl Swedberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Conclusions on the management of heart failure

Author(s) -

Karl Swedberg

Publication year - 2004

Publication title -

journal of the renin-angiotensin-aldosterone system

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.457

H-Index - 46

eISSN - 1752-8976

pISSN - 1470-3203

DOI - 10.3317/jraas.2004.023

Subject(s) - heart failure , aldosterone , medicine , management of heart failure , renin–angiotensin system , angiotensin receptor blockers , cardiology , angiotensin converting enzyme , intensive care medicine , pharmacology , blood pressure

Activity of the renin-angiotensin-aldosterone system (RAAS) is increased in heart failure. Agents which act on the RAAS can be expected to benefit these patients. Recent trials which have furthered our understanding of drugs which are of benefit in heart failure--angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, beta-blockers and aldosterone antagonists--are discussed. It is desirable to use multiple agents for best results in patients with heart failure. New European Society of Cardiology guidelines on the management of heart failure are expected later this year.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research